- You must enroll in this course to access course content.
Managing Antidepressant Adverse Events
Thirty-one point-of-care chapters on what to do when the antidepressant causes the problem — recognition, differential, and a management ladder for each adverse effect, built for the clinician who has eight minutes and a patient waiting.
Parts 1 to 3 are live — fourteen chapters published, two of them free to read. The remaining four parts follow every three to four days through 30 September.
What this course is for
Most antidepressant education answers the question of what to prescribe. This series answers the harder question that follows: the patient is on the drug, something has gone wrong, and you have to decide within the visit whether it is the illness, the medication, or something else entirely — and what to do about it.
Every chapter is built around the same clinical question. Is it the drug or the disease? Because that single discrimination determines whether you increase the dose, reduce it, add something, switch, or stop — and getting it backwards is how a treatable adverse effect becomes a treatment failure.
Decision-first structure
Bottom line up front, then the differential, then a numbered action ladder. The answer is in the first screen, not the last.
Numbers with denominators
Every incidence and mortality figure names its study population. Where the evidence is weak or contested, the chapter says so.
Built to use, not to read
Patient counselling scripts and copy-paste EMR notes in every chapter, so the work of the visit is already drafted.
📅 The September series
Every chapter of this course publishes in September 2026. Parts 1 to 3 are live now; the remaining four parts follow every three to four days, with the complete series — including the closing quick-reference matrix — live by 30 September.
Members get each part the day it publishes, at no additional cost, along with every other course in the Academy.
The 31 chapters
Serotonergic & Neuropsychiatric Effects
The emergencies and the misattributions — including the three presentations most often mistaken for worsening illness.
- 1Serotonin Syndrome
- 2Activation Syndrome & Treatment-Emergent Suicidality
- 3Antidepressant-Induced Akathisia
- 4Treatment-Emergent Mania & the Bipolar SwitchFree
- 5Tremor & Myoclonus
- 6Bruxism & Jaw Clenching
- 7Dystonia, Parkinsonism & Tardive Dyskinesia
GI, Sleep & Affect
The week-one complaints that make patients quit before the drug has had a chance to work.
- 8Nausea, Dyspepsia, Diarrhea & Dry Mouth
- 9Insomnia, Vivid Dreams & REM Sleep Effects
- 10Sedation & Daytime Somnolence
- 11Emotional Blunting, Apathy & Cognitive EffectsFree
Metabolic, Sexual & Long-Term
The effects patients do not volunteer, and the long-horizon risks that change the deprescribing conversation.
- 12Weight Gain & Appetite Change
- 13Sexual Dysfunction & PSSD
- 14Falls, Fractures & Bone Health
Cardiac, Autonomic & Bleeding
Monitoring thresholds, co-prescribing decisions, and the autonomic effects that get attributed to anxiety.
- 15QTc Prolongation, Tachycardia & Cardiac Conduction
- 16SNRI-Associated Hypertension
- 17Orthostatic Hypotension & Dizziness
- 18Antidepressant-Induced Excessive Sweating (ADIES)
- 19Urinary Retention & Incontinence
- 20Bleeding Risk: GI, Perioperative & Anticoagulant Co-Prescription
Laboratory, Stopping & Switching
The abnormal result you did not expect, and the two manoeuvres that cause more harm than any single adverse effect.
- 21Hyponatremia & SIADH
- 22Transaminitis & Drug-Induced Liver Injury
- 23Discontinuation Syndrome & Hyperbolic Tapering
- 24Switching & Cross-Taper Safety
Agent-Specific Sets
Five agents whose adverse-effect profiles differ enough from the SSRI pattern to need separate treatment.
- 25The Bupropion Set: Seizure Risk & Lowered Seizure Threshold — Bupropion and Beyond
- 26The Mirtazapine Set: Sedation, Appetite & Rare Neutropenia
- 27The Serotonin Modulator Set: Trazodone, Vilazodone & Vortioxetine
- 28The TCA Set: Anticholinergic Burden, Conduction Delay & Overdose Lethality
- 29The MAOI Set: Hypertensive Crisis, Tyramine & Washout Windows
Uncommon but Important + Quick Reference
The rare events worth recognising, and the grid that answers the question the whole series is built around.
- 30Rare but Serious: Angle-Closure Glaucoma, SJS/TEN, Blood Dyscrasias, Rhabdomyolysis, Hyperprolactinemia & Alopecia
- 31Quick-Reference Matrix: Antidepressant Adverse Event Grid
The closing matrix maps every adverse effect against every commonly prescribed agent, so the question “my patient developed this — what do I switch to?” has a single page as its answer.
Get every chapter as it publishes
One membership covers this series and the entire Academy library — psychopharmacology lessons, case discussions and clinical pearls, with new content added monthly.
Monthly
Flexible access without a long-term commitment.
Billed monthly. Cancel anytime.
Select MonthlyYearly
Our most popular plan. Save over 67% versus monthly.
Just $12.50 a month.
Select YearlyStudent & Resident
Discounted access for verified students and residents.
Verification of trainee status required.
ApplyAll 31 chapters, complete by 30 September
Parts 1 to 3 are live. The remaining parts unlock on 23, 26 and 30 September.
View pricing & join
Responses